Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Dec 2020
Historique:
received: 28 11 2020
revised: 16 12 2020
accepted: 29 12 2020
entrez: 5 1 2021
pubmed: 6 1 2021
medline: 7 4 2021
Statut: epublish

Résumé

MicroRNAs (miRNAs) are short, non-coding RNA species that are important post-transcriptional regulators of gene expression and play an important role in the pathogenesis of non-alcoholic fatty liver disease. Here, we investigated the phosphodiesterase 5 (PDE5) inhibitor induced effects on hepatic and plasma exosomal miRNA expression in CCl

Identifiants

pubmed: 33396535
pii: ijms22010382
doi: 10.3390/ijms22010382
pmc: PMC7795540
pii:
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0
Phosphodiesterase 5 Inhibitors 0
Carbon Tetrachloride CL2T97X0V0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Curr Gene Ther. 2015;15(2):142-50
pubmed: 25537773
Cell Rep. 2012 Dec 27;2(6):1537-45
pubmed: 23200856
Hepatology. 2013 Feb;57(2):432-4
pubmed: 22806606
Clin Chim Acta. 2013 Sep 23;424:99-103
pubmed: 23727030
J Basic Clin Physiol Pharmacol. 2018 Jan 26;29(1):29-35
pubmed: 29283882
Biochem Biophys Res Commun. 2019 Jan 22;508(4):1252-1258
pubmed: 30558790
Br J Pharmacol. 2015 Jul;172(13):3189-93
pubmed: 25964986
PLoS One. 2014 Dec 03;9(12):e113651
pubmed: 25470250
Clin Chem. 2010 Dec;56(12):1830-8
pubmed: 20930130
Hereditas. 2020 May 22;157(1):22
pubmed: 32443971
PLoS One. 2014 Aug 20;9(8):e105192
pubmed: 25141008
Curr Biol. 2002 Apr 30;12(9):735-9
pubmed: 12007417
J Biol Chem. 2012 Apr 27;287(18):14851-62
pubmed: 22393047
Sci Rep. 2020 Feb 25;10(1):3373
pubmed: 32099009
World J Gastroenterol. 2019 Nov 14;25(42):6322-6341
pubmed: 31754293
Hepatol Commun. 2020 Mar 13;4(5):670-680
pubmed: 32363318
PLoS One. 2011;6(8):e23937
pubmed: 21886843
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Clin Cancer Res. 2008 Jan 15;14(2):419-27
pubmed: 18223217
J Clin Invest. 2012 Aug;122(8):2871-83
pubmed: 22820288
Gastroenterology. 2010 Jul;139(1):323-34.e7
pubmed: 20347818
Sci Signal. 2013 Oct 08;6(296):ra88
pubmed: 24106341
Sci Rep. 2016 Feb 22;6:21510
pubmed: 26898400
Aliment Pharmacol Ther. 2016 Jan;43(1):102-13
pubmed: 26503793
Science. 2005 Sep 2;309(5740):1577-81
pubmed: 16141076
PLoS One. 2015 Nov 13;10(11):e0142661
pubmed: 26565986
Aliment Pharmacol Ther. 2007 Apr 15;25(8):883-9
pubmed: 17402991
Mol Ther Nucleic Acids. 2019 Jun 7;16:758-769
pubmed: 31150929
Hepatology. 2004 Dec;40(6):1387-95
pubmed: 15565570
Gastroenterology. 2009 Jan;136(1):320-330.e2
pubmed: 19013163
Br J Pharmacol. 2015 Jul;172(14):3461-71
pubmed: 26114403
Biochim Biophys Acta. 2014 Nov;1842(11):2237-45
pubmed: 25092172
Br J Pharmacol. 2018 Mar;175(6):953-967
pubmed: 29281143
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4402-7
pubmed: 19246379
Life Sci. 2017 Oct 15;187:22-30
pubmed: 28823564
Hepatology. 2008 Dec;48(6):1810-20
pubmed: 19030170
Microrna. 2018;7(3):215-222
pubmed: 29848284
Nat Rev Urol. 2014 Sep;11(9):499-507
pubmed: 25134838
Hepatology. 2011 Nov;54(5):1767-76
pubmed: 22045675
Proc Natl Acad Sci U S A. 2019 May 28;116(22):11057-11062
pubmed: 31085647
J Exp Med. 2018 Apr 2;215(4):1153-1168
pubmed: 29449309
J Hepatol. 2018 Dec;69(6):1335-1348
pubmed: 30142428
Gastroenterology. 2020 May;158(7):1984-1998.e3
pubmed: 32061596
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Hepatology. 2012 Nov;56(5):1946-57
pubmed: 22684891
Am J Pathol. 2002 May;160(5):1705-15
pubmed: 12000722
Am J Physiol Gastrointest Liver Physiol. 2006 Mar;290(3):G535-42
pubmed: 16269521
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Contemp Clin Trials. 2020 Feb;89:105922
pubmed: 31881392
J Clin Gastroenterol. 2011 Apr;45(4):355-60
pubmed: 21278583
Cancer Biomark. 2015;15(2):171-80
pubmed: 25519019
Sci Rep. 2018 Sep 25;8(1):14327
pubmed: 30254303
CMAJ. 2005 Mar 29;172(7):899-905
pubmed: 15795412
World J Hepatol. 2014 Aug 27;6(8):613-20
pubmed: 25232454
Liver Int. 2014 Aug;34(7):e302-7
pubmed: 24313922
Int J Mol Sci. 2018 Nov 22;19(12):
pubmed: 30469540
Int J Mol Sci. 2020 Aug 28;21(17):
pubmed: 32872119
J Clin Med. 2016 Mar 03;5(3):
pubmed: 26950158
Diabetes Res Clin Pract. 2013 Mar;99(3):327-34
pubmed: 23287814
J Autoimmun. 2009 May-Jun;32(3-4):246-53
pubmed: 19345069
Aliment Pharmacol Ther. 2010 Aug;32(3):487-97
pubmed: 20497147
Nat Commun. 2013;4:1831
pubmed: 23652019
J Hepatol. 2015 Feb;62(2):448-57
pubmed: 25308172
Fibrogenesis Tissue Repair. 2013 Oct 01;6(1):19
pubmed: 24274743
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Sci Rep. 2018 Jun 19;8(1):9372
pubmed: 29921982
Cell Metab. 2006 Feb;3(2):87-98
pubmed: 16459310
Gastroenterology. 2012 Jun;142(7):1592-609
pubmed: 22656328
PLoS Genet. 2013;9(2):e1003291
pubmed: 23459460
Oncogene. 2009 Oct 8;28(40):3526-36
pubmed: 19617899
Gut. 2015 May;64(5):800-12
pubmed: 24973316
Alcohol Clin Exp Res. 2009 Oct;33(10):1704-10
pubmed: 19572984
Dtsch Arztebl Int. 2014 Jun 27;111(26):447-52
pubmed: 25019921
J Hepatol. 2013 Mar;58(3):593-608
pubmed: 23419824
Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1468-1475
pubmed: 30840268
Nature. 2008 Apr 17;452(7189):896-9
pubmed: 18368051
Clin Sci (Lond). 2016 Jul 1;130(14):1197-207
pubmed: 27129188
Toxicol Appl Pharmacol. 2012 Jul 1;262(1):52-9
pubmed: 22561871
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Lab Invest. 2011 Feb;91(2):283-93
pubmed: 20956972
Cells. 2020 Apr 17;9(4):
pubmed: 32316690
Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):542-52
pubmed: 23689081
Sci Rep. 2015 Jun 22;5:11549
pubmed: 26096707

Auteurs

Andre Broermann (A)

Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach Germany.

Ramona Schmid (R)

Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Ogsen Gabrielyan (O)

Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Marlene Sakowski (M)

Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Claudia Eisele (C)

Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Sascha Keller (S)

Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Michael Wolff (M)

Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Patrick Baum (P)

Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Birgit Stierstorfer (B)

Drug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Jochen Huber (J)

Clinical Operations, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.

Bernhard K Krämer (BK)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, 68167 Mannheim, Germany.

Berthold Hocher (B)

Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Medicine, Hunan Normal University, 410078 Changsha, China.

Ruediger Streicher (R)

Cardiometabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach Germany.

Denis Delić (D)

Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorferstr.65, 88397 Biberach, Germany.
Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology), University Medical Centre Mannheim, University of Heidelberg, 68167 Mannheim, Germany.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH